← Back
$KYMR All transactions

Kymera Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$311K

Shares

6,349

Price

$49

Filed

Jun 3

Insider

Name

Albers Jeffrey W.

Title

CIK

0001638474

Roles

Director

Transaction Details

Transaction Date

2025-06-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 20, 2024 adopted by the reporting person. | The shares underlying this stock option are fully vested and exercisable.

Filing Info

Accession No.

0000950170-25-081198

Form Type

4

Issuer CIK

0001815442

Albers Jeffrey W.'s History

Date Ticker Type Value
2025-07-17 BPMC D
2025-07-17 BPMC U
2025-07-17 BPMC D
2025-07-17 BPMC D
2025-07-17 BPMC D
2025-07-17 BPMC D
2025-07-17 BPMC D
2025-07-17 BPMC D
2025-07-17 BPMC D
2025-07-17 BPMC D

Other Insiders at KYMR (90d)

Insider Bought Sold Last
Chadwick Jeremy G
Chief Operating Officer
$11.5M 2026-04-15
Booth Bruce $855K 2026-04-15
Ridloff Elena $1.0M 2026-04-01
Goodman Noah
Chief Business Officer
$1.0M 2026-04-14